Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Antimicrob Agents ; 34(3): 252-4, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19243922

RESUMO

Three fluoroquinolone-resistant Brucella melitensis mutants were obtained after successive passages on norfloxacin-containing agar plates. The original strain was B. melitensis biovar 2 ATCC 23457. Mutants emerged at frequencies ranging between 1 x 10(-6) and 3 x 10(-8). The three mutants showed a gyrA Ala71-->Ser mutation as well as insertion of Ala340. No mutations were observed in the parC and gyrB genes. Minimum inhibitory concentrations (MICs) increased by four- to eight-fold from the wild-type to the first-step mutant for norfloxacin, ciprofloxacin, levofloxacin and moxifloxacin. MICs of the second-step mutant increased significantly only for norfloxacin and those for the third-step mutant for norfloxacin and ciprofloxacin, suggesting the involvement of some efflux mechanism.


Assuntos
Antibacterianos/farmacologia , Brucella melitensis , Farmacorresistência Bacteriana/genética , Fluoroquinolonas/farmacologia , Mutação , Compostos Aza/farmacologia , Brucella melitensis/efeitos dos fármacos , Brucella melitensis/genética , Ciprofloxacina/farmacologia , DNA Girase/genética , DNA Topoisomerase IV/genética , DNA Bacteriano/análise , DNA Bacteriano/efeitos dos fármacos , DNA Bacteriano/genética , Levofloxacino , Testes de Sensibilidade Microbiana , Moxifloxacina , Norfloxacino/farmacologia , Ofloxacino/farmacologia , Quinolinas/farmacologia , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...